ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rivaroxaban Tablets Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-5C14447
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Rivaroxaban Tablets Market Research Report 2023
BUY CHAPTERS

Global Rivaroxaban Tablets Market Research Report 2025

Code: QYRE-Auto-5C14447
Report
May 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Janssen Pharmaceuticals
Beijing SL Pharmaceutical
Nanjing Zhengda Tianqing Pharmaceutical
Fujian Cosunter Pharmaceutical
Lunan Pharmaceutical
Cspc Holdings Company
Zhejiang Conba Pharmaceutical
Jiangsu Zhongbang Pharmaceutical
Shanghai Huilun Pharmaceutical
Jilin Boda Pharmaceutical
Suzhou No.3 Pharmaceutical
Chengdu Baiyu Pharmaceuticals

Rivaroxaban Tablets Market

The global market for Rivaroxaban Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Rivaroxaban tablets are anticoagulants (blood thinners) used to treat and prevent blood clots. Specifically, it is used to treat deep vein thrombosis and pulmonary embolism, and to prevent atrial fibrillation and blood clots after hip or knee surgery. It is taken orally. Common side effects include bleeding. Other serious side effects may include spinal epidural hematoma and anaphylactic shock. It is not known if it is safe to use during pregnancy and breastfeeding. It has fewer interactions with other drugs than warfarin. It works by blocking the activity of the clotting protein coagulation factor Xa.
North American market for Rivaroxaban Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rivaroxaban Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Rivaroxaban Tablets include Bayer, Janssen Pharmaceuticals, Beijing SL Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical, Fujian Cosunter Pharmaceutical, Lunan Pharmaceutical, Shanghai Huilun Pharmaceutical, Jilin Boda Pharmaceutical, Cspc Holdings Company, Zhejiang Conba Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rivaroxaban Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rivaroxaban Tablets.
The Rivaroxaban Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Boxes) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rivaroxaban Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rivaroxaban Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rivaroxaban Tablets Market Report

Report Metric Details
Report Name Rivaroxaban Tablets Market
Segment by Type
  • 2.5mg/Tablet
  • 10mg/Tablet
  • 15mg/Tablet
  • 20mg/Tablet
Segment by Application
  • Hospital
  • Clinic
  • Drugstore
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, Janssen Pharmaceuticals, Beijing SL Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical, Fujian Cosunter Pharmaceutical, Lunan Pharmaceutical, Shanghai Huilun Pharmaceutical, Jilin Boda Pharmaceutical, Cspc Holdings Company, Zhejiang Conba Pharmaceutical, Suzhou No.3 Pharmaceutical, Chengdu Baiyu Pharmaceuticals, Jiangsu Zhongbang Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rivaroxaban Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rivaroxaban Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Rivaroxaban Tablets Market report?

Ans: The main players in the Rivaroxaban Tablets Market are Bayer, Janssen Pharmaceuticals, Beijing SL Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical, Fujian Cosunter Pharmaceutical, Lunan Pharmaceutical, Shanghai Huilun Pharmaceutical, Jilin Boda Pharmaceutical, Cspc Holdings Company, Zhejiang Conba Pharmaceutical, Suzhou No.3 Pharmaceutical, Chengdu Baiyu Pharmaceuticals, Jiangsu Zhongbang Pharmaceutical

What are the Application segmentation covered in the Rivaroxaban Tablets Market report?

Ans: The Applications covered in the Rivaroxaban Tablets Market report are Hospital, Clinic, Drugstore

What are the Type segmentation covered in the Rivaroxaban Tablets Market report?

Ans: The Types covered in the Rivaroxaban Tablets Market report are 2.5mg/Tablet, 10mg/Tablet, 15mg/Tablet, 20mg/Tablet

Recommended Reports

Oral Anticoagulants

Anticoagulant Therapy

Thrombosis & Stroke

1 Rivaroxaban Tablets Market Overview
1.1 Product Definition
1.2 Rivaroxaban Tablets by Type
1.2.1 Global Rivaroxaban Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 2.5mg/Tablet
1.2.3 10mg/Tablet
1.2.4 15mg/Tablet
1.2.5 20mg/Tablet
1.3 Rivaroxaban Tablets by Application
1.3.1 Global Rivaroxaban Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstore
1.4 Global Rivaroxaban Tablets Market Size Estimates and Forecasts
1.4.1 Global Rivaroxaban Tablets Revenue 2020-2031
1.4.2 Global Rivaroxaban Tablets Sales 2020-2031
1.4.3 Global Rivaroxaban Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rivaroxaban Tablets Market Competition by Manufacturers
2.1 Global Rivaroxaban Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rivaroxaban Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rivaroxaban Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rivaroxaban Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rivaroxaban Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rivaroxaban Tablets, Product Type & Application
2.7 Global Key Manufacturers of Rivaroxaban Tablets, Date of Enter into This Industry
2.8 Global Rivaroxaban Tablets Market Competitive Situation and Trends
2.8.1 Global Rivaroxaban Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rivaroxaban Tablets Players Market Share by Revenue
2.8.3 Global Rivaroxaban Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rivaroxaban Tablets Market Scenario by Region
3.1 Global Rivaroxaban Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rivaroxaban Tablets Sales by Region: 2020-2031
3.2.1 Global Rivaroxaban Tablets Sales by Region: 2020-2025
3.2.2 Global Rivaroxaban Tablets Sales by Region: 2026-2031
3.3 Global Rivaroxaban Tablets Revenue by Region: 2020-2031
3.3.1 Global Rivaroxaban Tablets Revenue by Region: 2020-2025
3.3.2 Global Rivaroxaban Tablets Revenue by Region: 2026-2031
3.4 North America Rivaroxaban Tablets Market Facts & Figures by Country
3.4.1 North America Rivaroxaban Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rivaroxaban Tablets Sales by Country (2020-2031)
3.4.3 North America Rivaroxaban Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rivaroxaban Tablets Market Facts & Figures by Country
3.5.1 Europe Rivaroxaban Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rivaroxaban Tablets Sales by Country (2020-2031)
3.5.3 Europe Rivaroxaban Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rivaroxaban Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Rivaroxaban Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rivaroxaban Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Rivaroxaban Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Rivaroxaban Tablets Market Facts & Figures by Country
3.7.1 Latin America Rivaroxaban Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rivaroxaban Tablets Sales by Country (2020-2031)
3.7.3 Latin America Rivaroxaban Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rivaroxaban Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Rivaroxaban Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rivaroxaban Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rivaroxaban Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rivaroxaban Tablets Sales by Type (2020-2031)
4.1.1 Global Rivaroxaban Tablets Sales by Type (2020-2025)
4.1.2 Global Rivaroxaban Tablets Sales by Type (2026-2031)
4.1.3 Global Rivaroxaban Tablets Sales Market Share by Type (2020-2031)
4.2 Global Rivaroxaban Tablets Revenue by Type (2020-2031)
4.2.1 Global Rivaroxaban Tablets Revenue by Type (2020-2025)
4.2.2 Global Rivaroxaban Tablets Revenue by Type (2026-2031)
4.2.3 Global Rivaroxaban Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Rivaroxaban Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rivaroxaban Tablets Sales by Application (2020-2031)
5.1.1 Global Rivaroxaban Tablets Sales by Application (2020-2025)
5.1.2 Global Rivaroxaban Tablets Sales by Application (2026-2031)
5.1.3 Global Rivaroxaban Tablets Sales Market Share by Application (2020-2031)
5.2 Global Rivaroxaban Tablets Revenue by Application (2020-2031)
5.2.1 Global Rivaroxaban Tablets Revenue by Application (2020-2025)
5.2.2 Global Rivaroxaban Tablets Revenue by Application (2026-2031)
5.2.3 Global Rivaroxaban Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Rivaroxaban Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Rivaroxaban Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Rivaroxaban Tablets Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Janssen Pharmaceuticals
6.2.1 Janssen Pharmaceuticals Company Information
6.2.2 Janssen Pharmaceuticals Description and Business Overview
6.2.3 Janssen Pharmaceuticals Rivaroxaban Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Janssen Pharmaceuticals Rivaroxaban Tablets Product Portfolio
6.2.5 Janssen Pharmaceuticals Recent Developments/Updates
6.3 Beijing SL Pharmaceutical
6.3.1 Beijing SL Pharmaceutical Company Information
6.3.2 Beijing SL Pharmaceutical Description and Business Overview
6.3.3 Beijing SL Pharmaceutical Rivaroxaban Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Beijing SL Pharmaceutical Rivaroxaban Tablets Product Portfolio
6.3.5 Beijing SL Pharmaceutical Recent Developments/Updates
6.4 Nanjing Zhengda Tianqing Pharmaceutical
6.4.1 Nanjing Zhengda Tianqing Pharmaceutical Company Information
6.4.2 Nanjing Zhengda Tianqing Pharmaceutical Description and Business Overview
6.4.3 Nanjing Zhengda Tianqing Pharmaceutical Rivaroxaban Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Nanjing Zhengda Tianqing Pharmaceutical Rivaroxaban Tablets Product Portfolio
6.4.5 Nanjing Zhengda Tianqing Pharmaceutical Recent Developments/Updates
6.5 Fujian Cosunter Pharmaceutical
6.5.1 Fujian Cosunter Pharmaceutical Company Information
6.5.2 Fujian Cosunter Pharmaceutical Description and Business Overview
6.5.3 Fujian Cosunter Pharmaceutical Rivaroxaban Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Fujian Cosunter Pharmaceutical Rivaroxaban Tablets Product Portfolio
6.5.5 Fujian Cosunter Pharmaceutical Recent Developments/Updates
6.6 Lunan Pharmaceutical
6.6.1 Lunan Pharmaceutical Company Information
6.6.2 Lunan Pharmaceutical Description and Business Overview
6.6.3 Lunan Pharmaceutical Rivaroxaban Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lunan Pharmaceutical Rivaroxaban Tablets Product Portfolio
6.6.5 Lunan Pharmaceutical Recent Developments/Updates
6.7 Shanghai Huilun Pharmaceutical
6.7.1 Shanghai Huilun Pharmaceutical Company Information
6.7.2 Shanghai Huilun Pharmaceutical Description and Business Overview
6.7.3 Shanghai Huilun Pharmaceutical Rivaroxaban Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shanghai Huilun Pharmaceutical Rivaroxaban Tablets Product Portfolio
6.7.5 Shanghai Huilun Pharmaceutical Recent Developments/Updates
6.8 Jilin Boda Pharmaceutical
6.8.1 Jilin Boda Pharmaceutical Company Information
6.8.2 Jilin Boda Pharmaceutical Description and Business Overview
6.8.3 Jilin Boda Pharmaceutical Rivaroxaban Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Jilin Boda Pharmaceutical Rivaroxaban Tablets Product Portfolio
6.8.5 Jilin Boda Pharmaceutical Recent Developments/Updates
6.9 Cspc Holdings Company
6.9.1 Cspc Holdings Company Company Information
6.9.2 Cspc Holdings Company Description and Business Overview
6.9.3 Cspc Holdings Company Rivaroxaban Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cspc Holdings Company Rivaroxaban Tablets Product Portfolio
6.9.5 Cspc Holdings Company Recent Developments/Updates
6.10 Zhejiang Conba Pharmaceutical
6.10.1 Zhejiang Conba Pharmaceutical Company Information
6.10.2 Zhejiang Conba Pharmaceutical Description and Business Overview
6.10.3 Zhejiang Conba Pharmaceutical Rivaroxaban Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Zhejiang Conba Pharmaceutical Rivaroxaban Tablets Product Portfolio
6.10.5 Zhejiang Conba Pharmaceutical Recent Developments/Updates
6.11 Suzhou No.3 Pharmaceutical
6.11.1 Suzhou No.3 Pharmaceutical Company Information
6.11.2 Suzhou No.3 Pharmaceutical Description and Business Overview
6.11.3 Suzhou No.3 Pharmaceutical Rivaroxaban Tablets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Suzhou No.3 Pharmaceutical Rivaroxaban Tablets Product Portfolio
6.11.5 Suzhou No.3 Pharmaceutical Recent Developments/Updates
6.12 Chengdu Baiyu Pharmaceuticals
6.12.1 Chengdu Baiyu Pharmaceuticals Company Information
6.12.2 Chengdu Baiyu Pharmaceuticals Description and Business Overview
6.12.3 Chengdu Baiyu Pharmaceuticals Rivaroxaban Tablets Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Chengdu Baiyu Pharmaceuticals Rivaroxaban Tablets Product Portfolio
6.12.5 Chengdu Baiyu Pharmaceuticals Recent Developments/Updates
6.13 Jiangsu Zhongbang Pharmaceutical
6.13.1 Jiangsu Zhongbang Pharmaceutical Company Information
6.13.2 Jiangsu Zhongbang Pharmaceutical Description and Business Overview
6.13.3 Jiangsu Zhongbang Pharmaceutical Rivaroxaban Tablets Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Jiangsu Zhongbang Pharmaceutical Rivaroxaban Tablets Product Portfolio
6.13.5 Jiangsu Zhongbang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rivaroxaban Tablets Industry Chain Analysis
7.2 Rivaroxaban Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rivaroxaban Tablets Production Mode & Process Analysis
7.4 Rivaroxaban Tablets Sales and Marketing
7.4.1 Rivaroxaban Tablets Sales Channels
7.4.2 Rivaroxaban Tablets Distributors
7.5 Rivaroxaban Tablets Customer Analysis
8 Rivaroxaban Tablets Market Dynamics
8.1 Rivaroxaban Tablets Industry Trends
8.2 Rivaroxaban Tablets Market Drivers
8.3 Rivaroxaban Tablets Market Challenges
8.4 Rivaroxaban Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
Janssen Pharmaceuticals
Beijing SL Pharmaceutical
Nanjing Zhengda Tianqing Pharmaceutical
Fujian Cosunter Pharmaceutical
Lunan Pharmaceutical
Cspc Holdings Company
Zhejiang Conba Pharmaceutical
Jiangsu Zhongbang Pharmaceutical
Shanghai Huilun Pharmaceutical
Jilin Boda Pharmaceutical
Suzhou No.3 Pharmaceutical
Chengdu Baiyu Pharmaceuticals
List of Tables
 Table 1. Global Rivaroxaban Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Rivaroxaban Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Rivaroxaban Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Rivaroxaban Tablets Sales (K Boxes) of Key Manufacturers (2020-2025)
 Table 5. Global Rivaroxaban Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Rivaroxaban Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Rivaroxaban Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Rivaroxaban Tablets Average Price (US$/Box) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Rivaroxaban Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Rivaroxaban Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Rivaroxaban Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Rivaroxaban Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Rivaroxaban Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rivaroxaban Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rivaroxaban Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Rivaroxaban Tablets Sales by Region (2020-2025) & (K Boxes)
 Table 18. Global Rivaroxaban Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Rivaroxaban Tablets Sales by Region (2026-2031) & (K Boxes)
 Table 20. Global Rivaroxaban Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Rivaroxaban Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Rivaroxaban Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Rivaroxaban Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Rivaroxaban Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Rivaroxaban Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Rivaroxaban Tablets Sales by Country (2020-2025) & (K Boxes)
 Table 27. North America Rivaroxaban Tablets Sales by Country (2026-2031) & (K Boxes)
 Table 28. North America Rivaroxaban Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Rivaroxaban Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Rivaroxaban Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Rivaroxaban Tablets Sales by Country (2020-2025) & (K Boxes)
 Table 32. Europe Rivaroxaban Tablets Sales by Country (2026-2031) & (K Boxes)
 Table 33. Europe Rivaroxaban Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Rivaroxaban Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Rivaroxaban Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Rivaroxaban Tablets Sales by Region (2020-2025) & (K Boxes)
 Table 37. Asia Pacific Rivaroxaban Tablets Sales by Region (2026-2031) & (K Boxes)
 Table 38. Asia Pacific Rivaroxaban Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Rivaroxaban Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Rivaroxaban Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Rivaroxaban Tablets Sales by Country (2020-2025) & (K Boxes)
 Table 42. Latin America Rivaroxaban Tablets Sales by Country (2026-2031) & (K Boxes)
 Table 43. Latin America Rivaroxaban Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rivaroxaban Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Rivaroxaban Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Rivaroxaban Tablets Sales by Country (2020-2025) & (K Boxes)
 Table 47. Middle East and Africa Rivaroxaban Tablets Sales by Country (2026-2031) & (K Boxes)
 Table 48. Middle East and Africa Rivaroxaban Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Rivaroxaban Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Rivaroxaban Tablets Sales (K Boxes) by Type (2020-2025)
 Table 51. Global Rivaroxaban Tablets Sales (K Boxes) by Type (2026-2031)
 Table 52. Global Rivaroxaban Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Rivaroxaban Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Rivaroxaban Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Rivaroxaban Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Rivaroxaban Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Rivaroxaban Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Rivaroxaban Tablets Price (US$/Box) by Type (2020-2025)
 Table 59. Global Rivaroxaban Tablets Price (US$/Box) by Type (2026-2031)
 Table 60. Global Rivaroxaban Tablets Sales (K Boxes) by Application (2020-2025)
 Table 61. Global Rivaroxaban Tablets Sales (K Boxes) by Application (2026-2031)
 Table 62. Global Rivaroxaban Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Rivaroxaban Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Rivaroxaban Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Rivaroxaban Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Rivaroxaban Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Rivaroxaban Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Rivaroxaban Tablets Price (US$/Box) by Application (2020-2025)
 Table 69. Global Rivaroxaban Tablets Price (US$/Box) by Application (2026-2031)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer Rivaroxaban Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 73. Bayer Rivaroxaban Tablets Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. Janssen Pharmaceuticals Company Information
 Table 76. Janssen Pharmaceuticals Description and Business Overview
 Table 77. Janssen Pharmaceuticals Rivaroxaban Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 78. Janssen Pharmaceuticals Rivaroxaban Tablets Product
 Table 79. Janssen Pharmaceuticals Recent Developments/Updates
 Table 80. Beijing SL Pharmaceutical Company Information
 Table 81. Beijing SL Pharmaceutical Description and Business Overview
 Table 82. Beijing SL Pharmaceutical Rivaroxaban Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 83. Beijing SL Pharmaceutical Rivaroxaban Tablets Product
 Table 84. Beijing SL Pharmaceutical Recent Developments/Updates
 Table 85. Nanjing Zhengda Tianqing Pharmaceutical Company Information
 Table 86. Nanjing Zhengda Tianqing Pharmaceutical Description and Business Overview
 Table 87. Nanjing Zhengda Tianqing Pharmaceutical Rivaroxaban Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 88. Nanjing Zhengda Tianqing Pharmaceutical Rivaroxaban Tablets Product
 Table 89. Nanjing Zhengda Tianqing Pharmaceutical Recent Developments/Updates
 Table 90. Fujian Cosunter Pharmaceutical Company Information
 Table 91. Fujian Cosunter Pharmaceutical Description and Business Overview
 Table 92. Fujian Cosunter Pharmaceutical Rivaroxaban Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 93. Fujian Cosunter Pharmaceutical Rivaroxaban Tablets Product
 Table 94. Fujian Cosunter Pharmaceutical Recent Developments/Updates
 Table 95. Lunan Pharmaceutical Company Information
 Table 96. Lunan Pharmaceutical Description and Business Overview
 Table 97. Lunan Pharmaceutical Rivaroxaban Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 98. Lunan Pharmaceutical Rivaroxaban Tablets Product
 Table 99. Lunan Pharmaceutical Recent Developments/Updates
 Table 100. Shanghai Huilun Pharmaceutical Company Information
 Table 101. Shanghai Huilun Pharmaceutical Description and Business Overview
 Table 102. Shanghai Huilun Pharmaceutical Rivaroxaban Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 103. Shanghai Huilun Pharmaceutical Rivaroxaban Tablets Product
 Table 104. Shanghai Huilun Pharmaceutical Recent Developments/Updates
 Table 105. Jilin Boda Pharmaceutical Company Information
 Table 106. Jilin Boda Pharmaceutical Description and Business Overview
 Table 107. Jilin Boda Pharmaceutical Rivaroxaban Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 108. Jilin Boda Pharmaceutical Rivaroxaban Tablets Product
 Table 109. Jilin Boda Pharmaceutical Recent Developments/Updates
 Table 110. Cspc Holdings Company Company Information
 Table 111. Cspc Holdings Company Description and Business Overview
 Table 112. Cspc Holdings Company Rivaroxaban Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 113. Cspc Holdings Company Rivaroxaban Tablets Product
 Table 114. Cspc Holdings Company Recent Developments/Updates
 Table 115. Zhejiang Conba Pharmaceutical Company Information
 Table 116. Zhejiang Conba Pharmaceutical Description and Business Overview
 Table 117. Zhejiang Conba Pharmaceutical Rivaroxaban Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 118. Zhejiang Conba Pharmaceutical Rivaroxaban Tablets Product
 Table 119. Zhejiang Conba Pharmaceutical Recent Developments/Updates
 Table 120. Suzhou No.3 Pharmaceutical Company Information
 Table 121. Suzhou No.3 Pharmaceutical Description and Business Overview
 Table 122. Suzhou No.3 Pharmaceutical Rivaroxaban Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 123. Suzhou No.3 Pharmaceutical Rivaroxaban Tablets Product
 Table 124. Suzhou No.3 Pharmaceutical Recent Developments/Updates
 Table 125. Chengdu Baiyu Pharmaceuticals Company Information
 Table 126. Chengdu Baiyu Pharmaceuticals Description and Business Overview
 Table 127. Chengdu Baiyu Pharmaceuticals Rivaroxaban Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 128. Chengdu Baiyu Pharmaceuticals Rivaroxaban Tablets Product
 Table 129. Chengdu Baiyu Pharmaceuticals Recent Developments/Updates
 Table 130. Jiangsu Zhongbang Pharmaceutical Company Information
 Table 131. Jiangsu Zhongbang Pharmaceutical Description and Business Overview
 Table 132. Jiangsu Zhongbang Pharmaceutical Rivaroxaban Tablets Sales (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)
 Table 133. Jiangsu Zhongbang Pharmaceutical Rivaroxaban Tablets Product
 Table 134. Jiangsu Zhongbang Pharmaceutical Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Rivaroxaban Tablets Distributors List
 Table 138. Rivaroxaban Tablets Customers List
 Table 139. Rivaroxaban Tablets Market Trends
 Table 140. Rivaroxaban Tablets Market Drivers
 Table 141. Rivaroxaban Tablets Market Challenges
 Table 142. Rivaroxaban Tablets Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rivaroxaban Tablets
 Figure 2. Global Rivaroxaban Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rivaroxaban Tablets Market Share by Type: 2024 & 2031
 Figure 4. 2.5mg/Tablet Product Picture
 Figure 5. 10mg/Tablet Product Picture
 Figure 6. 15mg/Tablet Product Picture
 Figure 7. 20mg/Tablet Product Picture
 Figure 8. Global Rivaroxaban Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Rivaroxaban Tablets Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Drugstore
 Figure 13. Global Rivaroxaban Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Rivaroxaban Tablets Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Rivaroxaban Tablets Sales (2020-2031) & (K Boxes)
 Figure 16. Global Rivaroxaban Tablets Average Price (US$/Box) & (2020-2031)
 Figure 17. Rivaroxaban Tablets Report Years Considered
 Figure 18. Rivaroxaban Tablets Sales Share by Manufacturers in 2024
 Figure 19. Global Rivaroxaban Tablets Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Rivaroxaban Tablets Players: Market Share by Revenue in Rivaroxaban Tablets in 2024
 Figure 21. Rivaroxaban Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Rivaroxaban Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Rivaroxaban Tablets Sales Market Share by Country (2020-2031)
 Figure 24. North America Rivaroxaban Tablets Revenue Market Share by Country (2020-2031)
 Figure 25. United States Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Rivaroxaban Tablets Sales Market Share by Country (2020-2031)
 Figure 28. Europe Rivaroxaban Tablets Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Rivaroxaban Tablets Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Rivaroxaban Tablets Revenue Market Share by Region (2020-2031)
 Figure 36. China Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Rivaroxaban Tablets Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Rivaroxaban Tablets Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Rivaroxaban Tablets Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Rivaroxaban Tablets Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Rivaroxaban Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Rivaroxaban Tablets by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Rivaroxaban Tablets by Type (2020-2031)
 Figure 55. Global Rivaroxaban Tablets Price (US$/Box) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Rivaroxaban Tablets by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Rivaroxaban Tablets by Application (2020-2031)
 Figure 58. Global Rivaroxaban Tablets Price (US$/Box) by Application (2020-2031)
 Figure 59. Rivaroxaban Tablets Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Rivaroxaban Drugs Market Research Report 2024
Rivaroxaban API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Factor Xa Inhibitors Market Research Report 2024
Global Rivaroxaban Market Insights Forecast to 2030
Global Anticoagulant Medicines Market Research Report 2025
Global Enoxaparin Sodium Market Research Report 2024
Global Edoxaban Tosilate Tablets and Generic Drugs Market Research Report 2024
Global Warfarin Sodium Tablets Market Research Report 2024
Global Factor Xa Inhibitors Market Research Report 2024
Global Oral Anticoagulants Market Research Report 2024
Global Direct Oral Anticoagulants DOACs Market Research Report 2024
Global Direct Oral Anticoagulant Market Insights Forecast to 2030
Global Anticoagulant Reversal Agent Market Research Report 2024
Global Fraxiparine Market Research Report 2024
Global Nadroparin Calcium Market Research Report 2024
Global Anticoagulant Drugs Market Insights Forecast to 2030
Global Heparin Market Insights Forecast to 2030
Global Novel Oral Anticoagulants Drugs Market Insights Forecast to 2030
Global Injectable Blood Thinners Market Research Report 2025
Global Heparin Anticoagulant Market Insights Forecast to 2028
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions